Subscribe and Stay Informed
Receive industry-leading content from our experts
Start exploring
Q&A with Advarra’s Client Services Team Lead Kyle Naylor
https://advarra.wistia.com/medias/xuk0oq76qc Kyle Naylor didn’t set out to work in the IRB world—but once he found it, he…
A Practical Checklist for Building Confidence in Site Selection
How operational insight, performance data, and patient access signals can strengthen clinical trial site decisions …
Sponsor’s Guide to IRB Approval (Part VI): After IRB Approval: Compliance, Multi-Site Oversight, and Turning Review into a Strategic Advantage
IRB approval is a critical milestone in clinical research, but it isn’t the end of the oversight…
Do DSMBs Need AI Expertise?
Rethinking oversight as clinical trials become more data-driven and algorithm-informed As artificial intelligence (AI) becomes…
What Protocol Amendments Reveal About Trial Design
Key takeaways from ‘The Operational Realities of Protocol Amendments’ panel discussion at the Advarra Innovation…
Q&A with Advarra’s Manager of Ongoing Review MaryJo Carter
https://advarra.wistia.com/medias/nbwuqrazu4 MaryJo Carter has spent more than nine years at Advarra, growing alongside the organization and helping…